Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization

Rationale: Corneal neovascularization (CoNV) is a severe complication of various types of corneal diseases, that leads to permanent visual impairment. Current treatments for CoNV, such as steroids or anti-vascular endothelial growth factor agents, are argued over their therapeutic efficacy and adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiang-Hui, Tseng, Ching-Li, Lin, Fan-Li, Chen, Jinying, Hsieh, Erh-Hsuan, Lama, Suraj, Chuang, Yu-Fan, Kumar, Satheesh, Zhu, Linxin, McGuinness, Myra B., Hernandez, Jessika, Tu, Leilei, Wang, Peng-Yuan, Liu, Guei-Sheung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692906/
https://www.ncbi.nlm.nih.gov/pubmed/34976206
http://dx.doi.org/10.7150/thno.65098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692906/
https://www.ncbi.nlm.nih.gov/pubmed/34976206
http://dx.doi.org/10.7150/thno.65098

Ejemplares similares